AbbVie | Revenu Net



Net Income Changement Date
AbbVie USD 1.29B 1.31B 2025-03
Abbott USD 1.33B 7.9B 2025-03
ALKERMES USD 22.46M 344.61M 2025-03
Amgen USD 1.73B 1.1B 2025-03
AstraZeneca USD 2.92B 1.42B 2025-03
Biogen USD 240.5M 26.2M 2025-03
BioMarin Pharmaceutical USD 185.69M 60.74M 2025-03
Bristol-Myers Squibb USD 2.46B 2.38B 2025-03
Eisai JPY 949M 22.84B 2025-03
Eli Lilly USD 2.76B 1.65B 2025-03
Gilead Sciences USD 1.78B 529M 2024-12
GlaxoSmithKline GBP 1.62B 1.21B 2025-03
J&J USD 11B 7.57B 2025-03
Medtronic USD 1.06B 237M 2025-04
Merck USD 5.08B 1.34B 2025-03
Neurocrine Biosciences USD 103.1M 26.7M 2024-12
Novartis USD 2.82B 371M 2024-12
Pacira USD 4.81M 11.23M 2025-03
Perrigo USD -6400000 38.1M 2025-03
Pfizer USD 2.97B 2.56B 2025-03
Regeneron Pharmaceuticals USD 808.7M 109M 2025-03
Roche Holding CHF 1.01B 2.12B 2024-12
Sanofi EUR 1.87B 1.37B 2025-03
UCB EUR 104M 72M 2024-06
Ultragenyx Pharmaceutical USD -151080000 17.7M 2025-03
United Therapeutics USD 322.2M 20.9M 2025-03
Vertex Pharmaceuticals USD 913M 132.4M 2024-12
Zoetis USD 631M 50M 2025-03



AbbVie Revenu Net - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2025.